GlassScriptPhysician profile
Varun Rimmalapudi
NPI 1124330964
$8,826.24
in general payments reported to CMS, 2019-2025
27 companies · $1,148 in 2025
The $1,148 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,913 · 2020: $597 · 2021: $1,482 · 2022: $745 · 2023: $1,041 · 2024: $1,901 · 2025: $1,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,331 · Travel and Lodging: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,330.90 |
| Travel and Lodging | $758.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,445.96 | 2019-2025 | Eterna, Octrode, Proclaim |
| Boston Scientific Corporation | $2,346.99 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Si-Bone, INC. | $897.46 | 2024 | |
| Medtronic, INC. | $864.63 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $801.05 | 2019-2024 | Senza |
| Curonix LLC | $209.14 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $175.02 | 2019-2020 | |
| Foundation Fusion Solutions, LLC | $151.85 | 2024 | |
| Valinor Pharma, LLC | $145.04 | 2023-2025 | Movantik |
| Relievant Medsystems, INC. | $120.56 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $99.69 | 2020-2025 | Belbuca |
| Spr Therapeutics, INC | $74.98 | 2023-2025 | Sprint Pns System |
| Mml US, INC. | $72.77 | 2025 | Reactiv8 |
| Stimwave Technologies Incorporated | $67.76 | 2022 | |
| Flowonix Medical Incorporated | $65.19 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $62.14 | 2024 | Mild Device Kit |
| Biodelivery Sciences International, INC. | $36.52 | 2019-2021 | |
| Globus Medical, INC. | $32.56 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $23.81 | 2019 | |
| Nalu Medical, INC. | $22.94 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $19.13 | 2021 | |
| Bioventus LLC | $18.29 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.60 | 2024 | Relistor |
| Scilex Pharmaceuticals INC. | $16.59 | 2025 | |
| Horizon Therapeutics Plc | $14.46 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.79 | 2019 | |
| Baxter Healthcare | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Rimmalapudi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.